We observed a significant reduction in the frequency of CD226+ EFF and CD226+ EM CD8+ T cells in Rai stage III/IV CLL patients compared to those in Rai stages I/II and 0 (Fig. 2H). The gene discussed is CD226; the disease is B-cell chronic lymphocytic leukemia.